Navigation Links
Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
Date:2/6/2008

ALACHUA, Fla., Feb. 6 /PRNewswire-FirstCall/ -- Tutogen Medical, Inc. (Amex: TTG), a leading manufacturer of sterile biological implant products made from human (allograft) and animal (xenograft) tissue, today announced financial results for the first quarter of fiscal year 2008 ended December 31, 2007.

Highlights for the first quarter when compared to the previous year's first quarter include:

-- Total revenues increased 30%;

-- Revenues of dental products increased 27%;

-- Surgical specialty product revenues increased 73%;

-- U.S. revenues increased 30%;

-- International revenues increased 32%;

-- Excluding merger related costs, net income for the quarter would have

been $343,000 or $0.02 per fully diluted share, compared to a net

income of $361,000, or $0.02 per fully diluted share for the same

period last year.

As previously reported, on November 12, 2007, the Company entered into a merger agreement with Regeneration Technologies, Inc. The merger agreement provides that the Company's stockholders will receive 1.22 shares of Regeneration Technologies common stock for each share of the Company's stock that they own. Upon completion of the merger, the Company's stockholders will own approximately 45% of the combined company, on a fully diluted basis. The proposed merger is currently estimated to be completed later this month.

For the first quarter of fiscal year 2008, the Company reported revenues of $15.0 million compared to $11.5 million in the first quarter of the previous year; an increase of 30%. The gross margin for the first quarter was 54%, up from 50% in the fourth quarter. The first quarter gross margin of 54% was less than the g
'/>"/>

SOURCE Tutogen Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
3. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
4. Tutogen Medical, Inc. to Report Fourth Quarter and Fiscal Year 2007 Financial Results
5. Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results
6. Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. QMed, Inc. Reports July Medicare SNP Enrollments
9. Phlo Affiliate Reports Expanded Coverage to Oregon Border
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 ... presents Innovative Drug Delivery Systems: ... Licensing Opportunities for Generic Pharmaceutical ... There are more than ... drugs approved all over the ...
(Date:6/19/2013)... 19, 2013 India’s vast and ... potentially be worth up to a billion dollars ... Indian government is taking serious action to better ... , This presentation will examine:, , ...     Immediate and long term impacts , ...
(Date:6/19/2013)... Bellingham, Washington (PRWEB) June 18, 2013 ... on complex materials, costs and other trends will highlight ... in Monterey, California this fall. In its 33rd year, ... and includes an exhibition of key suppliers, approximately 100 ... by SPIE, the international society for optics and ...
(Date:6/19/2013)... 19, 2013 Adding to their already ... stocked with Simport’s Dropette® and Heathrow Scientific disposable ... customer doing basic biology, chemistry and any type of ... For over 35 years, Simport has been supplying the ... products like the Simport Dropette®. Simport’s Dropette® is a ...
Breaking Biology Technology:Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3Leading Pipette Distributor Pipette.com Now Stocks Transfer Pipettes: Simport’s Dropette and Heathrow Scientific Disposable Plastic Transfer Pipettes 2
... TAI,AN CITY, China, Nov. 13 /PRNewswire-Asia-FirstCall/ -- ... or the "Company"),one of the leading plasma-based pharmaceutical companies ... conference call at 8:00 a.m. ET on,Monday, November 16, ... on September 30, 2009. , ...
... PRINCETON, N.J., Nov. 13 Soligenix, Inc., (Soligenix ... known as DOR BioPharma, Inc., a late-stage biotechnology ... third quarter of 2009. , Highlights ... of enrollment in its confirmatory Phase 3 randomized, ...
... SHENYANG, China, Nov. 12 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. ... company,focused on researching, developing, manufacturing and marketing,biopharmaceutical products, today ... September 30, 2009. , , Third ... net revenues increased by 35.8% over the third quarter ...
Cached Biology Technology:China Biologic Schedules Conference Call to Discuss Third Quarter 2009 Financial Results 2Soligenix Reports Third Quarter 2009 Financial Results 2Soligenix Reports Third Quarter 2009 Financial Results 3Soligenix Reports Third Quarter 2009 Financial Results 4Soligenix Reports Third Quarter 2009 Financial Results 53SBio Inc. Announces Unaudited Third Quarter 2009 Results 23SBio Inc. Announces Unaudited Third Quarter 2009 Results 33SBio Inc. Announces Unaudited Third Quarter 2009 Results 43SBio Inc. Announces Unaudited Third Quarter 2009 Results 53SBio Inc. Announces Unaudited Third Quarter 2009 Results 63SBio Inc. Announces Unaudited Third Quarter 2009 Results 73SBio Inc. Announces Unaudited Third Quarter 2009 Results 83SBio Inc. Announces Unaudited Third Quarter 2009 Results 93SBio Inc. Announces Unaudited Third Quarter 2009 Results 103SBio Inc. Announces Unaudited Third Quarter 2009 Results 113SBio Inc. Announces Unaudited Third Quarter 2009 Results 123SBio Inc. Announces Unaudited Third Quarter 2009 Results 133SBio Inc. Announces Unaudited Third Quarter 2009 Results 143SBio Inc. Announces Unaudited Third Quarter 2009 Results 153SBio Inc. Announces Unaudited Third Quarter 2009 Results 163SBio Inc. Announces Unaudited Third Quarter 2009 Results 173SBio Inc. Announces Unaudited Third Quarter 2009 Results 183SBio Inc. Announces Unaudited Third Quarter 2009 Results 193SBio Inc. Announces Unaudited Third Quarter 2009 Results 203SBio Inc. Announces Unaudited Third Quarter 2009 Results 21
(Date:6/19/2013)... physiological anabolic agent for tissue-building and energy storage, ... and carbohydrates, and inhibiting their breakdown and release ... major role in stimulating glucose entry into muscle ... from the blood following meals. But gaps exist ... insulin regulates glucose uptake in fat and muscle ...
(Date:6/19/2013)... N.Y. A Cornell University study offers further proof ... million to 6 million years ago was profoundly influenced ... turning genes on and off. , The study, published ... for a 40-year-old hypothesis that regulation of genes must ... little difference between humans and chimps in the proteins ...
(Date:6/18/2013)... June 19, 2013  Paris Air Show – ... Test Systems) , a leading provider of innovative ... is demonstrating its solutions this week at the ... With growing challenges including increasingly complex armament systems ... feature-rich, specialized aerospace test solutions that address legacy ...
Breaking Biology News(10 mins):Breakthrough research of essential molecule reveals important targets in diabetes and obesity 2New research backs theory that genetic 'switches' play big role in human evolution 2New research backs theory that genetic 'switches' play big role in human evolution 3Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 2Marvin Test Solutions Demonstrates Next-Generation Armament Test Solutions at Paris Air Show 3
... Va.--To cut down on convoys trucking fuel to forward ... the Navy,s vision for energy efficiency, the Office of ... have successfully demonstrated their goal to reduce petroleum and ... early results from the front indicate the ability of ...
... found that in 14 independent studies, the yields of ... biofuel feedstocks, such as corn, soybean, sorghum, and wheat. ... yet been evaluated exist. According to bioenergy analyst, ... low risk of unintended land use change. Biomass from ...
... The most common connective tissue cell in animals is the ... But Dr. Neta Erez of Tel Aviv University,s Sackler Faculty ... a body great harm, helping to "recruit" immune cells for ... creation when cancer cell proliferation is beginning, fibroblasts rush to ...
Cached Biology News:ONR, Marine Corps show alternative energy use at forward operating bases can save dollars, lives 2ONR, Marine Corps show alternative energy use at forward operating bases can save dollars, lives 3Infiltrating cancer's recruitment center 2
... is an intelligent full microplate washer with a ... This instrument gives you the best of two ... , Performance ,Separate wash and ... efficiency. A dispense precision of better than 2% ...
... This system uses the Adept CE 4100 ... CE 4200 dual wavelength detector for ... PowerStream data processing software and interface unit, CE ... Windows XP may also be used with Windows ...
...
... separations of DNA larger than 2, ... megabase pairs. This agarose has the highest gel strength of any electrophoresis agarose ... preparation ... ...
Biology Products: